BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2001
View Archived Issues
Schering AG provides update at annual press conference
Read More
Encouraging preclinical results reported for Titan's controlled-release buprenorphine
Read More
NVP-DPP-728 improves glucose tolerance in rat model
Read More
Schering AG's liver-specific contrast agent approved in Sweden
Read More
NeoPharm files IND for liposomal mitoxantrone
Read More
Yamanouchi and Pharmacia amend celecoxib agreement for Japan
Read More
New vaccine targets for cancer-causing strains of HPV identified
Read More
Oxeze Turbuhaler approved in Canada for control and relief of asthma symptoms
Read More
NPS and AstraZeneca join forces in drug development alliance
Read More
Dainippon's AR inhibitor improves diabetic neuropathy in laboratory study
Read More
Phase I/II evaluation of Titan's Pivanex begins in liver cancer
Read More
CPMP issues positive opinion for Fabrazyme
Read More
Micafungin heading for regulatory filings this year and next
Read More
PG-TXL proves superior to free paclitaxel against human colon cancer xenografts
Read More
AACR presentation points to potential new indication for ABX-IL-8: melanoma
Read More
AACR news: preliminary phase I/II results with Vaxid indicate good safety, immunogenicity
Read More
PEG-Intron/Rebetol combination for hepatitis C treatment approved in E.U.
Read More
Voluntary withdrawal of injectable anesthesia drug by Organon
Read More
Tumstatin exerts antiangiogenic and apoptotic effects according to preclinical studies
Read More
Drotrecogin alfa (activated) granted FDA priority review for severe sepsis
Read More
European approval granted for Sanofi-Synthelabo's Fasturtec
Read More
Pyrrolidine-based influenza neuraminidase inhibitors under study at Abbott
Read More
Potent and selective MC4 receptor antagonists useful for weight and pigmentation disorders
Read More
Japanese researchers describe potential new therapy for diastolic heart failure
Read More
Hydroxamic acid-based MMP inhibitors disclosed by Novartis
Read More
BASF presents new vitronectin inhibitors and possible uses thereof
Read More
Potassium channel blockers targeting the slow delayed rectifier designed by Merck
Read More
Glycine-site NMDA receptor antagonists discovered at Gruenenthal
Read More
New erythromycin derivatives from Taisho exert potent antibacterial activity
Read More